Swipe om te navigeren naar een ander artikel
Twenty-two children with autism spectrum disorders who had not responded to supported behaviour management strategies for severe dysomnias entered a double blind, randomised, controlled crossover trial involving 3 months of placebo versus 3 months of melatonin to a maximum dose of 10 mg. 17 children completed the study. There were no significant differences between sleep variables at baseline. Melatonin significantly improved sleep latency (by an average of 47 min) and total sleep (by an average of 52 min) compared to placebo, but not number of night wakenings. The side effect profile was low and not significantly different between the two arms.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Armour, D., & Paton, C. (2004). Melatonin in the treatment of insomnia in children and adolescents. Psychiatric Bulletin, 28, 222–224. CrossRef
Bramble, D., & Feehan, C. (2005). Psychiatrists’ use of melatonin with children. Child and Adolescent Mental Health, 10(3), 145–149. CrossRef
Coppola, G., Iervolino, G., Mastrosimone, M., La Torre, G., Ruiu, F., & Pascotto, A. (2004). Melatonin in wake sleep disorders in children, adolescents and young adults with mental retardation with and without epilepsy: A double blind, cross over placebo controlled trial. Brain Development, 26(6), 373–376. CrossRefPubMed
Council Directive (EC) 2001/20/EC of the European parliament and of the council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.
DeMuro, R. L., Nafziger, A. N., Blask, D. E., Menhinick, A. M., & Bertino, J. S. (2000). The absolute bioavailability of oral melatonin. The Journal of Clinical Pharmacology, 40, 781–784. CrossRef
Dickerson Mayes, S., & Calhoun, S. L. (2009). Variables related to sleep problems in children with autism. Research in Autism Spectrum Disorders, 3(4), 931–941. CrossRef
Dodge, N. N., & Wilson, G. A. (2001). Melatonin for treatment of sleep disorders in children with developmental disabilities. Journal of Child Neurology, 16, 581–584. PubMed
Einfield, S. L., & Tonge, B. J. (1989). The Developmental Behaviour Checklist. Melbourne Australia: Monash University Centre For Developmental Psyhciatry.
Galli-Carminati, G., Deriaz, N., & Bertschy, G. (2009). Melatonin in the treatment of chronic sleep disorders in adults with autism: A retrospective study. Swiss med weekly, 139(19–20), 293–296.
Garstang, J., & Wallis, M. (2006). Randomised controlled trial of melatonin for children with autistic spectrum disorders and sleep problems. Child: Care, Health and Development, 32, 585–589. CrossRef
Goldberg, D. (1992). General health questionnaire (GHQ-12). Windsor, UK: Nfer-Nelson.
Hoshino, Y., Watanabe, H., Yashima, Y., Kaneko, M., & Kumashiro, H. (1984). An investigation on the sleep disturbance of autistic children. Folia Psychiatrica et Neurologica Japonica, 38, 45–51. PubMed
Ishizaki, A., et al. (1999). Usefulness of melatonin for developmental sleep and emotional/behavior disorders-studies of melatonin trial on 50 patients with developmental disorders. No To Hattatsu, 31(5), 428–437. PubMed
Ivanenko, A., Crabtree, V. M., Tauman, R., et al. (2003). Melatonin in children and adolescents with insomnia: a retrospective study. Clinical Paediatrics, 42, 51–58. CrossRef
Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Leventhal, B. L., DiLavore, P. C., et al. (2001). The autism diagnostic observation schedule—generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30, 205–223. CrossRef
Malow, B. A., Marzec, M. L., McGrew, S. G., Wang, L., Henderson, L. M., & Stone, W. L. (2006). Characterising sleep in children with autism spectrum disorders: A multidimensional approach. Sleep, 29, 1563–1571. PubMed
Minde, K., Faucon, A., & Faulkner, S. (1994). Sleep problems in toddlers, effects of treatment on their daytime behaviour. Journal of American Academy of Child and Adolescent Psychiatry, 33, 1114–1121. CrossRef
Mulchahey, J. J., Goldwater, D. R., & Zemlan, F. P. (2004). A single blind placebo controlled across groups dose escalation study of the safety, tolerability, pharmacokinetics, pharmacodynamics of the melatonin analog Beta-methyl-6-chloromelatonin. Life Sciences, 75, 1843–1856. PubMed
National Autistic Society (2009, December 15th). Sleep and autism: Helping your child. Retrieved from http://www.nas.org.uk/nas/jsp/polopoly.jsp?d=528&a=3376.
Norton, P., & Drew, C. (1994). Autism and potential family stressors. The American Journal of Family Therapy, 22(1), 67–76. CrossRef
O’Connell A, Chapparo C (2002) The trouble with sleeping can a waterbed help? Inaugural World Autism Conference.
Quine, L. (1992). Severity of sleep problems in children with severe learning disabilities: Description and correlates. Journal of Community and Applied Social Psychology, 2, 247–268. CrossRef
Quine, L. (2001). Sleep problems in primary school children: Comparison between mainstream and special school children care. Health and Development., 37(3), 201–221. CrossRef
Ramachandani, P., Wiggs, L., Webb, V., & Stores, G. (2000). A systematic review of treatments for settling problems and night waking in young children. BMJ, 320, 209–213. CrossRef
Sack, R. L., Hughs, R. J., Edgar, D. M., & Lewy, A. J. (1997). Sleep-promoting effects of melatonin. At what dose, in whom, under what circumstances, and by what mechanisms? Sleep, 20, 908–915. PubMed
Smits, M. G., Nagtegaal, E. E., Van Der Heijden, R., et al. (2001). Melatonin for chronic onset sleep disorder in children: A randomised placebo-controlled trial. Journal of Child Neurology, 16, 86–92. PubMed
Smits, M. G., Van Stel, H. F., Van Der Heijden, R., et al. (2003). Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: A randomised placebo-controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1286–1293. CrossRefPubMed
Sutherland, E. R., Martin, R. J., Ellison, M. C., & Kraft, M. (2002). Immunomodulatory effects of melatonin in asthma. American Journal of Respiratory Critical care Medicine, 166, 1055–1061. CrossRef
WHO (1993). The ICD—10 Classification of mental and behavioural disorders:- Diagnostic Criteria for Research: General World Health Organisation.
Wasdell, M. B., Jan, J. E., Bomben, M. M., Freeman, R. D., Rietveld, W. J., Tai, J., et al. (2008). A randomised, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. Journal of Pineal Research, 44, 57–64. PubMed
World Health Organisation (1993). The ICD – 10 Classification of Mental and Behavioural Disorders:- Diagnostic Criteria for Research: General World Health Organisation.
- Melatonin Versus Placebo in Children with Autism Spectrum Conditions and Severe Sleep Problems Not Amenable to Behaviour Management Strategies: A Randomised Controlled Crossover Trial
- Springer US